Cargando…
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment
Immunotherapies and immune checkpoint inhibitors (ICI) represent the latest revolution in oncology. Several studies have reported an association between the use of corticosteroids and poorer outcomes for patients treated with ICIs. However, it has been never established whether corticoid-induced tum...
Autores principales: | Gougis, Paul, Abbar, Baptiste, Benzimra, Julie, Vozy, Aurore, Spano, Jean-Philippe, Campedel, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406741/ https://www.ncbi.nlm.nih.gov/pubmed/36010283 http://dx.doi.org/10.3390/diagnostics12081933 |
Ejemplares similares
-
Bone remodeling by checkpoint inhibitor
por: Kim, Hyeongjong, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors (Nivolumab)-Induced Enterocolitis Demonstrated on (18)Fluorine-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
por: Usmani, Sharjeel, et al.
Publicado: (2019) -
Histiocytic Sarcoma: Challenging Course, Dismal Outcome
por: Andersen, Kim Francis, et al.
Publicado: (2021) -
Clinical course of severe esophagitis following bevacizumab therapy
por: Choi, Jun-Ho, et al.
Publicado: (2022) -
Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study
por: Gougis, P., et al.
Publicado: (2022)